SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
14709576
Source:
http://linkedlifedata.com/resource/pubmed/id/14709576
Search
Subject
(
51
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0008976
,
umls-concept:C0015737
,
umls-concept:C0040833
,
umls-concept:C0278329
,
umls-concept:C1274040
,
umls-concept:C1521798
pubmed:issue
1
pubmed:dateCreated
2004-1-7
pubmed:abstractText
Research on factors that influence prescribing patterns and the extent of change produced by clinical trial findings is limited.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/R01-HS013405
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/14709576-14709583
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7501160
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic alpha-Antagonists
,
http://linkedlifedata.com/resource/pubmed/chemical/Antihypertensive Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Doxazosin
,
http://linkedlifedata.com/resource/pubmed/chemical/Drugs, Generic
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1538-3598
pubmed:author
pubmed-author:AlehegnTsedayT
,
pubmed-author:CockburnIain MIM
,
pubmed-author:FinkelsteinStan NSN
,
pubmed-author:FurbergCurt DCD
,
pubmed-author:NEWWW
,
pubmed-author:StaffordRandall SRS
pubmed:issnType
Electronic
pubmed:day
7
pubmed:volume
291
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
54-62
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:14709576-Adrenergic alpha-Antagonists
,
pubmed-meshheading:14709576-Antihypertensive Agents
,
pubmed-meshheading:14709576-Clinical Trials as Topic
,
pubmed-meshheading:14709576-Doxazosin
,
pubmed-meshheading:14709576-Drug Utilization
,
pubmed-meshheading:14709576-Drugs, Generic
,
pubmed-meshheading:14709576-Evidence-Based Medicine
,
pubmed-meshheading:14709576-Humans
,
pubmed-meshheading:14709576-Hypertension
,
pubmed-meshheading:14709576-Physician's Practice Patterns
,
pubmed-meshheading:14709576-United States
pubmed:year
2004
pubmed:articleTitle
Impact of clinical trial results on national trends in alpha-blocker prescribing, 1996-2002.
pubmed:affiliation
Stanford Prevention Research Center, Stanford University, Stanford, Calif 94305, USA. rstafford@stanford.edu
pubmed:publicationType
Journal Article
,
Research Support, U.S. Gov't, P.H.S.